Biocodex Strengthens Supply Chain Resilience with Kinaxis
Business Wire India Biocodex, a pioneer and leader in human microbiota health, as well as an innovator in pharmaceuticals, has partnered with Kinaxis® Inc. (TSX: KXS), a global leader in…
Business Wire India Biocodex, a pioneer and leader in human microbiota health, as well as an innovator in pharmaceuticals, has partnered with Kinaxis® Inc. (TSX: KXS), a global leader in…
Business Wire India Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today kicked off the enrollment for a Phase III clinical…
Business Wire India Adcendo exercises its option to utilize Biocytogen’s fully human antibodies to further expand its ADC pipeline for cancers with high unmet medical need This collaboration further validates…
Business Wire India TECNO, the global smartphone brand known for its innovative technology, is a proud partner of DPIFF 2025, honouring the rich cultural heritage of Indian cinema. Aligned with…
Business Wire India The moto g35 5G will go on sale today, 12 PM onwards, on Flipkart, Motorola.in and leading retail stores across India, at an effective price of just…
Business Wire India The Global Loan Agency Services Group (“GLAS”) is delighted to confirm the successful completion of its acquisition of Watiga Trust and Watiga Asia (collectively, “Watiga”). This press…
Business Wire India Ad hoc announcement pursuant to Art. 53 LR Approximately 7% of people in the United States (U.S.) have atopic dermatitis – a common, chronic, and flaring inflammatory…
Business Wire India Today, Experian announced its 2024 Global Identity & Fraud Report that provides a comprehensive view of the consumer and business response to the latest fraud patterns and…
Business Wire India Temporal Technologies today announced the availability of Temporal Cloud on Google Cloud Marketplace, offering developers in the Google Cloud ecosystem the most streamlined path to using Temporal…
Business Wire India BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and Cellistic, a leader in advanced iPS cell…